
Tactile Systems (TCMD) Stock Forecast & Price Target
Tactile Systems (TCMD) Analyst Ratings
Bulls say
Tactile Systems Technology Inc. is demonstrating notable growth potential, as evidenced by its increased fiscal year 2025 revenue guidance, which was raised by $6.5 million to a range of $317-$321 million, reflecting anticipated strong performance in the lymphedema and AffloVest businesses. The company is benefiting from strategic initiatives, including an expanded sales force and enhanced productivity through advanced technology, which are contributing to improved operational metrics and a projected gross margin of approximately 75%. Additionally, the favorable market dynamics, including streamlined patient access and leadership in the pneumatic compression pump sector, position Tactile Systems Tech for sustained growth moving into fiscal year 2026.
Bears say
Tactile Systems Technology Inc. has experienced a downward revision in its Lymphedema sales growth expectations, which has directly contributed to lower projected revenues for the fourth quarter of 2025, despite higher performance in Airway Clearance. The company faces significant risks, including slower uptake in commercial channels, workforce optimization issues, and competitive pressures, which could hinder future performance, especially since nearly 85% of revenues are derived from this segment. Additionally, the ongoing visibility challenges stemming from two consecutive guidance reductions raise concerns about the sustainability of Tactile Systems' growth trajectory.
This aggregate rating is based on analysts' research of Tactile Systems and is not a guaranteed prediction by Public.com or investment advice.
Tactile Systems (TCMD) Analyst Forecast & Price Prediction
Start investing in Tactile Systems (TCMD)
Order type
Buy in
Order amount
Est. shares
0 shares